Rheumatoid arthritis and bronchiectasis: A multicentre study assessing pulmonary disease severity using the bronchiectasis severity index (BSI)

A. De Soyza, J. Davison, M. McDonnell, E. Perry, S. Aliberti, P. Goeminne, J. Chalmers, A. Hill (Newcastle upon Tyne, Barnstable, Dundee, Edinburgh, United Kingdom; Galway, Ireland; Milan, Italy; Leuven, Belgium)

Source: International Congress 2014 – Interventions and other therapeutic approaches in respiratory infections
Session: Interventions and other therapeutic approaches in respiratory infections
Session type: Poster Discussion
Number: 245

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. De Soyza, J. Davison, M. McDonnell, E. Perry, S. Aliberti, P. Goeminne, J. Chalmers, A. Hill (Newcastle upon Tyne, Barnstable, Dundee, Edinburgh, United Kingdom; Galway, Ireland; Milan, Italy; Leuven, Belgium). Rheumatoid arthritis and bronchiectasis: A multicentre study assessing pulmonary disease severity using the bronchiectasis severity index (BSI). Eur Respir J 2014; 44: Suppl. 58, 245

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Co-existent rheumatoid arthritis and non-cystic fibrosis bronchiectasis: Evidence for more severe pulmonary disease using the bronchiectasis severity index (BSI)
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014

Rheumatoid arthritis is a common and important comorbidity in bronchiectasis: Data from the EMBARC European bronchiectasis registry
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016

Rheumatoid arthritis and comorbid chronic obstructive or interstitial pulmonary diseases: Prevalence in a population-based cohort
Source: International Congress 2016 – Burden of respiratory diseases: from environmental aspects to healthcare consumption
Year: 2016

Comparative analysis of the predictive utility of clinical disease severity scores for non-cystic fibrosis bronchiectasis
Source: International Congress 2014 – Epidemiology, scores and outcomes of respiratory infections
Year: 2014


Prevalence of extra-pulmonary comorbidities in COPD patients and its correlation with severity of disease
Source: International Congress 2014 – Latest insights in chronic care
Year: 2014

The bronchiectasis severity index (BSI) and FACED score for assessment the severity of bronchiectasis
Source: International Congress 2016 – Monitoring comorbidities
Year: 2016


Study of inflammatory markers and BODE index in patients with chronic obstructive pulmonary disease
Source: International Congress 2016 – Systemic biomarkers
Year: 2016


Factors contributing to severe pneumonia in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – Healthcare, prevention and adjunctive treatments in respiratory infections
Year: 2014


Clinical presentation of chronic obstructive pulmonary disease (COPD): Study on-sint
Source: International Congress 2014 – Clinical assessment of airway diseases
Year: 2014


Impact of co-morbidities on disease severity and risk of mortality in non-cystic fibrosis bronchiectasis
Source: International Congress 2015 – Adult bronchiectasis: risk factors and future perspectives
Year: 2015


Associations between severity of airflow obstruction and atherosclerosis: A cross-sectional study in Japan
Source: International Congress 2014 – Prevalence of COPD and mortality from COPD
Year: 2014


Impact of bronchiectasis on the course of COPD
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016


Psychiatric co-morbidity in patients admitted with acute exacerbation of chronic pulmonary disease and its relationship with symptom severity
Source: International Congress 2016 – Comorbidities and exacerbations in COPD
Year: 2016


Chronic obstructive pulmonary disease and sudden cardiac death: The Rotterdam study
Source: International Congress 2015 – COPD and lung function: risk factors and outcomes
Year: 2015


Chronic obstructive pulmonary disease (COPD) exacerbations and carotid artery plaques: The Rotterdam study
Source: Annual Congress 2013 –Comorbidities and respiratory disease and late-breaking abstracts
Year: 2013

Prevalence of co-morbidities with chronic obstructive pulmonary disease (COPD) in a primary care cohort
Source: International Congress 2014 – Clinical presentations
Year: 2014


Frequency of depression in patients with chronic obstructive pulmonary disease
Source: International Congress 2014 – The assessment of comorbidities
Year: 2014

Exacerbations of bronchiectasis requiring hospitalization; clinical characteristics and outcomes
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016

Predicting hospital admissions in non-CF bronchiectasis using COPD specific severity tools
Source: Annual Congress 2013 –Treating bronchiectasis in respiratory patients
Year: 2013


Predictors of exacerbations in hospitalised patients with bronchiectasis: A retrospective study in an Asian population
Source: International Congress 2015 – Clinical assessment and monitoring of asthma and COPD
Year: 2015